CDSCO flags 27 formulations as not of standard quality
In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) flagged 27 medicine batches for failing to qualify for a random drug sample test for the month of January.
These drug samples including Bochem Healthcare's Ferrous Sulphate & Folic Acid Tablets IP, Zee Laboratories' NITZO -2.6 (Controlled Release Tablets of Nitrogylcerin), Skymap Pharmaceuticals' WARZYME Digestive Enzymes (Pepsin & Fungal Diastase Syrup), Ortin Laboratories' Enalapril Maleate Tablets IP 5 mg, Om Biomedic's Pantoprazole Gastro- Resistant Tablets I.P., Terrace Pharmaceutical's Atenolol Tablets IP 50 mg and others are declared as 'Not of Standard Quality'.
For more information check out the full story on the link below:
Drug Alert: CDSCO Flags 27 Formulations As Not Of Standard Quality
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.